Chargement en cours...
Anemia Management in the Era of Triple Combination Therapy for Chronic HCV
Boceprevir or telaprevir plus ribavirin (RBV) and pegylated interferon-α (pegIFN-α) is the new standard-of-care therapy for patients who are chronically infected with genotype 1 hepatitis C virus (HCV). The addition of these protease inhibitors to the RBV/pegIFN-α combination regimen has significant...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Millennium Medical Publishing
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3533206/ https://ncbi.nlm.nih.gov/pubmed/23293572 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|